 |
|
Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
Pin-Jin Hu
Intest Res. 2015;13(3):188-190. Published online 2015 Jun 9 DOI: https://doi.org/10.5217/ir.2015.13.3.188
|
|
Citations to this article as recorded by
 Crohn’s Disease Among the Poorest Billion: Burden of Crohn’s Disease in Low- and Lower-Middle-Income Countries
Ruma Rajbhandari, Samantha Blakemore, Neil Gupta, Sara Mannan, Klejda Nikolli, Alison Yih, Laura Drown, Gene Bukhman
Digestive Diseases and Sciences.2023; 68(4): 1226. CrossRef The cost of illness analysis of inflammatory bowel disease
Majid Pakdin, Leila Zarei, Kamran Bagheri Lankarani, Sulmaz Ghahramani
BMC Gastroenterology.2023;[Epub] CrossRef Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' Consortium
Rupa Banerjee, Partha Pal, Ida Hilmi, Uday C Ghoshal, Devendra C Desai, Mohammed Masudur Rahman, Usha Dutta, Syed A Mohiuddin, Munnera Al Mohannadi, Mathew Philip, Ganesh N Ramesh, Madunil A Niriella, Arjuna P De Silva, Hithanadura Janaka de Silva, Pises
Journal of Gastroenterology and Hepatology.2022; 37(6): 1004. CrossRef Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia
Rupa Banerjee, Partha Pal, Joyce Wing Yan Mak, Siew C Ng
The Lancet Gastroenterology & Hepatology.2020; 5(12): 1076. CrossRef Crohn’s disease in low and lower-middle income countries: A scoping review
Ruma Rajbhandari, Samantha Blakemore, Neil Gupta, Alma J Adler, Christopher Allen Noble, Sara Mannan, Klejda Nikolli, Alison Yih, Sameer Joshi, Gene Bukhman
World Journal of Gastroenterology.2020; 26(43): 6891. CrossRef Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
Intestinal Research.2018; 16(2): 233. CrossRef Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence
Seow-Neng Chan, Eden Ngah Den Low, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar
Intestinal Research.2018; 16(3): 374. CrossRef The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia‐Pacific region ‐ background and recommendations of a regional consensus meeting
Uday C Ghoshal, Kok‐Ann Gwee, Gerald Holtmann, Yanmei Li, Soo Jung Park, Marcellus Simadibrata, Kentaro Sugano, Kaichun Wu, Eamonn M M Quigley, Henry Cohen
Journal of Gastroenterology and Hepatology.2018; 33(1): 57. CrossRef Ophthalmologic manifestations in patients with inflammatory bowel disease
Hye Jin Lee, Hyun Joo Song, Jin Ho Jeong, Heung Up Kim, Sun-Jin Boo, Soo-Young Na
Intestinal Research.2017; 15(3): 380. CrossRef Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn’s disease
Kyunghwan Oh, Eun Hye Oh, Seunghee Baek, Eun Mi Song, Gwang-Un Kim, Myeongsook Seo, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, John Green
PLOS ONE.2017; 12(6): e0179266. CrossRef Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang
Intestinal Research.2017; 15(3): 338. CrossRef Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development
Mingsong Kang, Alberto Martin
Seminars in Immunology.2017; 32: 3. CrossRef Overall and cause‐specific mortality in Korean patients with inflammatory bowel disease: A hospital‐based cohort study
Ho‐Su Lee, Jaewon Choe, Seon‐Ok Kim, Sun‐Ho Lee, Hyo Jeong Lee, Hyungil Seo, Gwang‐Un Kim, Myeongsook Seo, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Yong Sik Yoon, Chang S
Journal of Gastroenterology and Hepatology.2017; 32(4): 782. CrossRef Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
Intestinal Research.2017; 15(4): 475. CrossRef Protective effects of heat-killed Lactococcus lactis subsp. lactis BF3, isolated from the intestine of chum salmon, in a murine model of DSS-induced inflammatory bowel disease
Toru NAKATA, Shino HIRANO, Yasushi YOKOTA, Hajime TAKAHASHI, Bon KIMURA, Takashi KUDA, Tadashi ETO, Michiko KATO
Bioscience of Microbiota, Food and Health.2016; 35(3): 137. CrossRef Current status of biosimilars in the treatment of inflammatory bowel diseases
Dong Il Park
Intestinal Research.2016; 14(1): 15. CrossRef Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease
Sung Wook Hwang, Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Sang Hyoung Park, Ho-Su Lee, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim, Suk-Kyun Yang
Journal of Crohn's and Colitis.2016; 10(9): 1024. CrossRef Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
Gut and Liver.2016; 10(4): 595. CrossRef The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?
Rashid N.S. Lui, Siew C. Ng
Inflammatory Intestinal Diseases.2016; 1(2): 78. CrossRef
|